Skip to content
Search AI Powered

Latest Stories

The Controversy Surrounding Delta-8 THC: Legal or Prohibited Substance?

A recent revelation from a Drug Enforcement Administration (DEA) official has shed light on the agency's stance on Delta-8 THC, sparking discussions about its classification and implications for the industry.

Drug Enforcement Administration (DEA) stance on Delta-8 THC Stirs Controversy
Drug Enforcement Administration (DEA) stance on Delta-8 THC Stirs Controversy

In the wake of the rapid expansion of the hemp industry and the increasing popularity of CBD products, a new cannabinoid has emerged on the market—delta-8 THC. While its popularity has been on the rise, so has the confusion and debate over its legality. 

A recent revelation from a Drug Enforcement Administration (DEA) official has shed light on the agency's stance on Delta-8 THC, sparking discussions about its classification and implications for the industry.


DEA's Clear Position on Delta-8 THC

In a recent post on his Substack platform, attorney Shane Pennington uncovered a 2021 letter from DEA Drug & Chemical Evaluation Section Chief Terrence Boos. The letter left no room for ambiguity: when delta-8 THC is synthesized from legal CBD, it is considered a prohibited controlled substance. Boos explained that the chemical transformation of CBD into delta-8 THC renders the latter synthetic and, therefore, ineligible for exemption under the Agriculture Improvement Act of 2018, which federally legalized hemp. Boos' message was succinct and straightforward: "Any quantity of delta-8-THC obtained by chemical means is a controlled substance."

This interpretation has significant implications for the delta-8 THC industry, which has witnessed rapid growth in recent years following the legalization of hemp-derived products. The cannabinoid has also become a subject of legal disputes, with various states banning its sale and distribution.

The Legal Battle and Industry Impact

Delta-8 THC's legality has been a matter of contention, with numerous lawsuits challenging the policies of states that have banned its sale. Attorney Shane Pennington's findings underscore the DEA's stance, but questions remain about the interpretation of the relevant statutes. Pennington expressed skepticism about Boos' interpretation, highlighting potential conflicts between the terms "derivative" and "extract" in the Farm Bill and the DEA's perspective.

Pennington's argument is echoed by other legal experts, including attorney Matthew Zorn. They argue that the Farm Bill's language excludes hemp and its derivatives from the Controlled Substances Act (CSA), suggesting that Congress intended to permit semi-synthetic hemp derivatives like delta-8 THC. This position challenges the DEA's rigid classification of delta-8 THC as a controlled substance.

DEA's Response and Future Developments

At the DEA's 2023 Supply Chain Conference in May, Terrence Boos reiterated the agency's stance, emphasizing that synthetic cannabinoids are prohibited. He announced that the DEA is working on a final rule to formally solidify this policy, a move recommended by the U.S. Department of Health and Human Services (HHS). Boos' stance is also consistent with his earlier communication that minor cannabinoids like delta-8 THC-0 and delta-9 THC-O are considered prohibited due to their synthetic production.

Legal Nuances and Potential Cracks in Logic

While the DEA remains resolute in its position, legal experts contend that the agency's reasoning has gaps. They point out that DEA's historical use of broad statutory language to prohibit derivatives and extracts conflicts with the Farm Bill's specific exclusion of hemp and its derivatives from CSA regulations. The attorneys assert that this inconsistency constitutes arbitrary and capricious agency action.

Supporting their argument, a federal appeals court ruled last year that delta-8 THC is exempt from control, as the law remains "silent" on this minor cannabinoid while expressly legalizing hemp extracts and derivatives. However, Pennington and Zorn stress that it's crucial to acknowledge the DEA's authority, as Boos' views are likely to hold sway unless challenged in court or addressed by Congress.

Despite the DEA's firm stance on delta-8 THC, the market for products containing this cannabinoid continues to thrive. Several states have moved to ban these products, but the Food and Drug Administration (FDA) has primarily issued warning letters to specific companies that it deems problematic. This suggests that federal enforcement measures have not been uniformly strict.

In the broader context of the cannabis industry, DEA Administrator Anne Milgram has signaled a willingness to consider new evidence and recommendations. As part of an administrative review initiated by President Joe Biden, the DEA is awaiting a scientific assessment and scheduling recommendation on marijuana from the U.S. Department of Health and Human Services (HHS).

The controversy surrounding delta-8 THC underscores the complexities and challenges that arise as the cannabis industry expands and evolves. The DEA's firm stance on the synthetic cannabinoid's legality clashes with legal arguments that point to potential inconsistencies and gaps in the agency's reasoning. As debates continue, industry stakeholders, legal experts, and policymakers will play pivotal roles in shaping the future of delta-8 THC and its place in the broader landscape of cannabis derivatives. Until then, the market's growth remains dynamic, influenced by shifting legal interpretations and regulatory responses.

More For You

Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
U.S. States with highest revenue from cannabis taxes
U.S. States with highest revenue from cannabis taxes

U.S. States with the Highest Revenue from Cannabis Taxes

The Drug Enforcement Agency (DEA) hasn't seen any reason to remove cannabis from its list of Schedule I banned substances. Yet, cannabis in its myriad forms is pulling in billions of dollars in vital tax revenue for those states where it is legal —$3 billion in 2022 alone.

The drug has sat in the Schedule I classification alongside heroin, peyote, and other substances the DEA considers to have a high potential for abuse since 1970, when Congress enacted the Controlled Substances Act, making it federally illegal to possess them. Two decades after the law passed, following intense social pressure that segued into the realization of a new tax opportunity, certain states began to make the drug available to residents, citing the medical benefits and relative safety compared with other substances

Keep ReadingShow less
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Photo by Axel Antas-Bergkvist on Unsplash

Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness

Kanye West, aka Ye, isn’t just trending—he’s unraveling in real time. And instead of intervention, we get viral clips, condemnation, and an audience watching a man self-destruct. His latest stunt? Airing a Super Bowl ad promoting a swastika-emblazoned Yeezy shirt on his site—a move so blatantly antisemitic that even the most die-hard supporters had to step back. This act garnered significant media coverage, leading to brands cutting ties and agents dropping him. His social media account faced scrutiny and was ultimately deleted after a history of controversial postings. But here’s the problem: canceling Kanye doesn’t fix Kanye.

At this point, the question isn’t whether his actions are inexcusable (they are). The question is, what happens when one of the world’s most influential figures is also one of the most untreated cases of mental illness in pop culture history?

Keep ReadingShow less
gif of actor Kevin James from King of Queens; asking "How Much Does That Cost?"
Why Is Some Weed More Expensive Than Others? Understanding Cannabis Pricing
Giphy

Unraveling Cannabis Pricing: Factors Behind the Cost of Weed


Step inside a cannabis dispensary for the first time and the experience can be overwhelming. The meticulously labeled glass jars showcase dozens of strains with names like "Wedding Cake" and "Blue Dream," while refrigerated cases display concentrates, edibles, and tinctures at wildly different price points. Unlike the days when consumers were limited to whatever their neighborhood dealer offered, today's legal market presents a dazzling array of options that might leave newcomers with both wonder and sticker shock.

Keep ReadingShow less
image of a circle of doctors and surgeons standing over and looking at a patient on operating room table
New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up
Photo by National Cancer Institute on Unsplash

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.

Keep ReadingShow less